Search
![](https://static.wixstatic.com/media/6516fb_5719fe921136464f95b68b75db277e24~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/6516fb_5719fe921136464f95b68b75db277e24~mv2.jpg)
![MHRA Guidance: MAH Submission of Nitrosamine Risk Evaluation, Risk Assessment and Confirmatory Testing](https://static.wixstatic.com/media/6516fb_5719fe921136464f95b68b75db277e24~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/6516fb_5719fe921136464f95b68b75db277e24~mv2.jpg)
Sharan Murugan
- Jan 18
- 2 min
MHRA Guidance: MAH Submission of Nitrosamine Risk Evaluation, Risk Assessment and Confirmatory Testing
Nitrosamines have become a significant concern in the pharmaceutical industry due to their potential carcinogenicity. In response to this...
65 views0 comments
![](https://static.wixstatic.com/media/nsplsh_b5d243a730c342b59c629ba1c39d25f7~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_b5d243a730c342b59c629ba1c39d25f7~mv2.jpg)
![ICH - Q9(R1) Quality Risk Management Draft Guidance Uupdation](https://static.wixstatic.com/media/nsplsh_b5d243a730c342b59c629ba1c39d25f7~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_b5d243a730c342b59c629ba1c39d25f7~mv2.jpg)
Sharan Murugan
- Jun 18, 2022
- 2 min
ICH - Q9(R1) Quality Risk Management Draft Guidance Uupdation
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) It is commonly understood...
20 views0 comments